ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
98 286,72
0,18%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Roquefort Therapeutics Plc (ROQ) Cours

Roquefort Therapeutics Plc

Roquefort Therapeutics Plc (ROQ)

LSE
4,18
-0,02
(-0,48%)
Fermé 04 Janvier 5:30PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
4,18
Prix Achat
3,80
Prix Vente
4,10
Volume échangé
848 155
3,95 Fourchette du Jour 4,25
3,35 Plage de 52 semaines 9,25
Cap du marché
5,398M
Clôture Veille
4,20
Ouverture
4,20
Dernière Transaction
8000
@
4.18
(UT)
Dernière heure de transaction
Volume financier
35 453p
VWAP
4,18
Volume moyen (3 m)
1 522 780
Actions en circulation
129 149 998
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,93
Bénéfice par action (BPA)
-0,01
Chiffre d'affairess
200k
Bénéfice net
-1,75M

À propos de Roquefort Therapeutics Plc

Secteur
Cmp Integrated Sys Design
Industrie
Cmp Integrated Sys Design
Site Web
www.roquefortplc.com
Siège social
London, Gbr
Fondé
-
Roquefort Therapeutics Plc est coté dans le secteur Cmp Integrated Sys Design de la London Stock Exchange avec le ticker ROQ. Le dernier cours de clôture d'Roquefort Therapeutics était de 4,20p. Au cours de la dernière année, les actions de Roquefort Therapeutics ont été négociées dans une fourchette de prix de 3,35p à 9,25p.

Roquefort Therapeutics compte actuellement 129 149 998 actions en circulation. La capitalisation boursière d'Roquefort Therapeutics est de £5,42 million. Roquefort Therapeutics a un ratio cours/bénéfice (ratio PE) de -2.93.

ROQ Dernières nouvelles

Plus de nouvelles

Roquefort Therapeutics proposes USD10 million subsidiary sale

Roquefort Therapeutics PLC on Thursday said it has proposed the sale of subsidiary Lyramid Pty Ltd to Pleiades Pharma ...

02 Janvier 2025
Alliance News

Roquefort Therapeutics PLC Proposed Sale of Midkine Portfolio

Roquefort Therapeutics PLC 02 January 2025   2 January 2025 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Proposed Sale of Midkine Portfolio   Roquefort Therapeutics...

02 Janvier 2025
RNS Regulatory News

Roquefort Therapeutics PLC Director Share Distribution

Roquefort Therapeutics PLC 04 December 2024   4 December 2024   Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company")   Director Share Distribution   Roquefort Therapeutics...

04 Décembre 2024
RNS Regulatory News

Roquefort Therapeutics PLC Conversion of Convertible Loan Notes

Roquefort Therapeutics PLC 07 November 2024   7 November 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Conversion of Convertible Loan Notes   Roquefort...

07 Novembre 2024
RNS Regulatory News

EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart

The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...

27 Septembre 2024
Alliance News

Roquefort Therapeutics PLC Interim Results to 30 June 2024

Roquefort Therapeutics PLC 27 September 2024   27 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company")   Interim Results to 30 June 2024   Roquefort...

27 Septembre 2024
RNS Regulatory News

Roquefort Therapeutics says MK cell therapy patent approved in Japan

Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approve ...

23 Septembre 2024
Alliance News
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.133.209876543214.0553.915516344.13536455DE
40.030.7228915662654.1553.810208524.19371313DE
120.235.822784810133.956.753.615227804.64191828DE
26-0.57-124.756.753.358335424.53380493DE
52-3.07-42.34482758627.259.253.355612554.75810797DE
156-6.32-60.190476190510.511.253.353689336.43966031DE
260-1.82-30.3333333333613.53.353026316.55085003DE

ROQ - Frequently Asked Questions (FAQ)

What is the current Roquefort Therapeutics share price?
The current share price of Roquefort Therapeutics is 4,18p
How many Roquefort Therapeutics shares are in issue?
Roquefort Therapeutics has 129 149 998 shares in issue
What is the market cap of Roquefort Therapeutics?
The market capitalisation of Roquefort Therapeutics is GBP 5,42M
What is the 1 year trading range for Roquefort Therapeutics share price?
Roquefort Therapeutics has traded in the range of 3,35p to 9,25p during the past year
What is the PE ratio of Roquefort Therapeutics?
The price to earnings ratio of Roquefort Therapeutics is -2,93
What is the cash to sales ratio of Roquefort Therapeutics?
The cash to sales ratio of Roquefort Therapeutics is 26,33
What is the reporting currency for Roquefort Therapeutics?
Roquefort Therapeutics reports financial results in GBP
What is the latest annual turnover for Roquefort Therapeutics?
The latest annual turnover of Roquefort Therapeutics is GBP 200k
What is the latest annual profit for Roquefort Therapeutics?
The latest annual profit of Roquefort Therapeutics is GBP -1,75M
What is the registered address of Roquefort Therapeutics?
The registered address for Roquefort Therapeutics is 85 GREAT PORTLAND STREET, FIRST FLOOR, LONDON, W1W 7LT
What is the Roquefort Therapeutics website address?
The website address for Roquefort Therapeutics is www.roquefortplc.com
Which industry sector does Roquefort Therapeutics operate in?
Roquefort Therapeutics operates in the CMP INTEGRATED SYS DESIGN sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCFTheracryf Plc
0,725p
(38,10%)
7,56M
NMTNeometals Ltd
3,50p
(27,27%)
346,81k
SCHOScholium Group Plc
44,00p
(25,71%)
30,65k
FABFusion Antibodies Plc
10,15p
(24,54%)
3,34M
PYXPyx Resources Limited
3,49p
(22,24%)
8,43k
TM1Technology Minerals Plc
0,125p
(-24,24%)
37,21M
QUIZQuiz Plc
0,70p
(-18,60%)
3,67M
SYMESupply@me Capital Plc
0,003p
(-17,81%)
168,35M
OBDOxford Biodynamics Plc
1,20p
(-14,29%)
827,83k
ZENZenith Energy Ltd.
5,25p
(-13,93%)
5,39M
TRPTower Resources Plc
0,0395p
(5,33%)
539,51M
CPXCap-xx Limited
0,1825p
(1,39%)
494M
NTVONativo Resources Plc
0,0019p
(0,00%)
320,16M
DGIDg Innovate Plc
0,0225p
(-13,46%)
208,21M
ENETEthernity Networks Ltd
0,1125p
(2,27%)
207,56M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
ROQ
Roquefort Therapeutics
BIT
UB60NE
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés